ABUS vs ICCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ABUS

55.5
AI Score
VS
ABUS Wins

ICCM

52.8
AI Score

Investment Advisor Scores

ABUS

56score
Recommendation
HOLD

ICCM

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS ICCM Winner
Forward P/E 10.2459 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -90.6% 72.8% ICCM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.5/100 52.8/100 ABUS
Profit Margin 84.2% 0.0% ABUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABUS 1M: -5.5% · 3M: -15.2% ICCM 1M: -30.8% · 3M: -74.6%

Current Technical Phase

ABUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.5%), weak momentum, RSI 40

RSI (14): 40.2 · Price: $3.89

ICCM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -33.6%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $0.76

Fundamentals Snapshot

Metric ABUS ICCM
Market Cap — —
Forward P/E -34.4 -0.2
Trailing P/E 4.7 —
Revenue (TTM) — —
Revenue Growth -0.9% 0.7%
Gross Margin 0.9% 0.4%
Operating Margin -5.7% -4.9%
EPS 0.79 -6.84
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.